To: From: Cc: Bcc: Received Date: Subject: Cagen, Stuart Z SCC </O=SHELUOU=MSXSCC/CN=RECIPIENTS/CN=SC724012> Gerhard Gans <gansg@basf-corp.com> 2002-10-17 21 :34:56 GMT Re: Benzene epidemiology studies in Shanghai Dear Dr.

Attachment E For Discussion Action By Subscribing Companies API Executive Committee June 19, 2003 China Benzene/Shanghai Heath Study Issue: Absent significant slippage in the project timetable; the participating companies should determine and communicate their decision, if they plan not to go forward with the project, before the group convenes at its Annual Meeting in California at the end of August.

Benzene Health Research Consortium Budget May 6,2005 * Histology consultant included since this service is a subcontra ct for the DP/ME studies.

F.l Cases of Severe AA, MDS, AML, BID or BP Cases Subjects will be recruited to the study by hospital Clinical Coordinators on the basis of initial clinical presentation, clinical history and/or previous preliminary blood work.

To: From: Cc: Bcc: Received Date: Subject: Clegg, Patsy M SCC-DCS/22 <patsy.clegg@shell.com> Wong, Zachary (ZachWong) <ZachWong@chevron.com> 2007-01-1618:36:50 GMT FW: My Input on Shanghai Quality Team Charter!

To: From: Cc: Bcc: Received Date: Subject: 'Russell White (E-mail).

Shanghai Health Study Update to Shell Sponsors and Stakeholders February 27, 2006 Background The Shanghai Health Study (SHS), sponsored by the Benzene Health Research Consortium (BHRC) of which Shell Chemicals is a member, is a multi-stakeholder health study in Shanghai, China, which aims to better define potential human health hazards and risks associated with exposure to benzene.

To: Briggs, Barnaby <Barnaby.D.Briggs@opc.shell.com>; Cagen, Stuart <SC724012@MSXSCC.SHELL.COM>; Clegg, Patsy <PH197432@MSXSCC.SHELL.COM>; Colletti, Sarah <sarah.colletti@shell.com>; De Jong, Geert <Geert.G.deJong@Sl.shell.com>; lannarone, Lauren <Lauren.lannarone@shell.com>; Simpson, Edward <Edward.Simpson@shell.com>; Sullivan, Nancy <NS196769@MSXSCC.SHELL.COM>; Tholstrup, Susan <susan.tholstrup@shell.com>; Tsai, Shan <ST196949@MSXSOC.SHELL.COM> From: Clegg, Patsy M SCC-CHSE-PC </O=SHE LUOU=MSXSCC/CN=RE CI PI ENTS/CN=PH197432> Cc: Bcc: Received Date: 2004-01-2319:36:57 GMT Subject: FW: Shanghai Health Study Update: January 23,2004 Weekly update of the SHS provided by API.

To: From: Cc: Bcc: Received Date: Subject: Tholstrup, Susan C SCC <susan.tholstrup@sheILcom>; Sullivan, Nancy E SCC-CBAR <nancy.sullivan@sheILcom>; Clegg, Patsy M SCC-CHSE-PC <patsy.clegg@shell.com>; lannarone, Lauren B SCC-CSEA <Lauren.lannarone@sheILcom>; Samuel, Tarita B SCC darita.samuel@shell.com>; Tsai, Shan SP SHLOIL-SHLOIL-HE <Shan.Tsai@sheILcom> Cagen, Stuart Z SCC <lO=SHELLlOU=MSXSCC/CN=RECI PI ENTS/CN=SC724012> Owen, David DE SC-CHSE-DO <david.owen@sheILcom> 2003-06-1614:37:29 GMT Shanghai Health Study - Science All: As requested, please find attached a draft one page document that summarizes scientific perspectives of the Shanghai study - prepared by Shan and myself.

Dan Hunter ConocoPhillips 281-293-2862 From: bette. park @bakerbotts. com [mailto: bette. park @bakerbotts. com1 Sent: Monday, July 09,20071 :00 PM To: Hunter, Dan Subject: TIP 2007-112/ TCEQ Taking Comment on Proposed ESL Revisions - Emerging Issues The following document has been added to the BakerBottsiTexas Industry Project extranet.

From: Lorraine Twerdok [Twerdokl@api.org] Sent: Tuesday, February 24,20048:04 AM To: Jim Williams; Howard Feldman; Ed Murphy; Clegg, Patsy M SCC-CHSE-PC; Brian Doll (E-mail) Cc: Pat Cackowoski Subject: Friday Morning's Meeting - when & where Patsy, Brian, Ed, Jim, and Howard The meeting on Friday will be: Topic Benzene Health Research Consortium (BHRC) Briefing Date: Friday, February 27, 2004 Time: 9:30 AM - 10:30 AM Location: Conference room 1012 (API offices in DC) Attendees: Patsy Clegg (Shell Chemical), Chair of BHRC Oversight Committee Brian Doll, (ExxonMobil), Co-Chair of BHRC Oversight Committee Howard Feldman (API).

From: Jmricewas@aol.com Sent: Monday, October 16,2006 10:58 AM To: idanpaanj@who.int; juhana. idanpaan@pp.fimnet.fi; xzllzx@citiz.net; Ralbert315@aol.com; checko@u.washington.edu; rlarson@medicine.bsd. uchicago. edu; guilanli@263.net.cn; minden@uhnres. utoronto. ca; herbst@pitt.edu; ellen. w. c1ayton@Vanderbilt.edu; john. cherrie@iomhq.org.uk; john. cherrie@blueyonder.co.uk; helmut. greim@lrz.tu-muenchen.de; hh. greim@t-online.de; herrick@hohp.harvard.edu; plombardo@gsu.edu Cc: Bruce Jamot; Russell White Subject: Update on the Shanghai Health Study Attachments: CC Progress report rev 08-09-2006.pdf Dear Colleagues, I am writing to provide you with important updates on the current status of the Shanghai Health Study.

From: George Woodall [Woodallg@api.org] Sent: Wednesday, August 08,2001 9:36 AM To: 'BenzConsort-OC@listserve.api.org' Cc: Lorraine Twerdok; Harry Ng; John Wagner; Paula Podhasky Subject: Conference call needed - Consortium form decision Importance: High To all, Please respond ASAP with your availability for a call either on Friday of this week, or Monday or Tuesday of next week (8/10, 8/13 or 8/14).

described.

BHRC OVERSIGHT, TECHNICAL, COMMUNICATIONS COMMITTEES CALL MINUTES July 22, 2009 Attendees: Stuart Cagen, Shell Patsy Clegg (Chair), Shell Brian Doll, ExxonMobil Howard Feldman, API Mark Fitzsimmons, Steptoe and Johnson Jennifer Galvin, ConocoPhillips Laura Keating, ExxonMobil Eric Stine, Chevron John Wagner, API Russ White, API Quorum Present Antitrust Guidelines reviewed Decisions/Actions: 1.